MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$4,106,817
(-92.85%↓ Y/Y)
Net loss
-$4,105,801
(-92.57%↓ Y/Y)
Foreign currency
translation adjustment
-$1,016
(-140.80%↓ Y/Y)
Loss from operations
-$4,080,664
(-91.38%↓ Y/Y)
Total other income
(expenses), net
-$25,137
(-12668.50%↓ Y/Y)
Dividend and interest
income
$168
(-16.00%↓ Y/Y)
Total operating
expenses
$4,080,664
(91.38%↑ Y/Y)
Unrealized loss on crypto
assets
$25,305
General and
administrative expenses
$2,447,188
(98.19%↑ Y/Y)
Research and development
expense
$1,633,476
(82.00%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. (HOTH)